COSENTYX is included on most of formularies
for commercially insured patients1*
COSENTYX is included on most of formularies
for commercially insured patients1*
With the COSENTYX $0 co-pay† program,
98% of enrollees‡ paid nothing out of pocket2
With the COSENTYX $0 co-pay† program,98%of enrollees‡ paid nothing out of pocket2
Up to 2 years of FREE COSENTYX is available
with Covered Until You're Covered for qualified‡§
commercially insured patients if a PA is denied
while coverage is pursued
Up to 2 years of FREE COSENTYX is available with Covered Until You're Covered for qualifiedठcommercially insured patients if a PA is denied while coverage is pursued
Our coverage and support help minimize
disruption, and help your eligible patients
START and STAY on COSENTYX
Uninsured or underinsured patients will be connected to the Novartis Patient Assistance Program to see if they are eligible for financial assistance.
*COSENTYX is present on formularies as either first-, second-, third-, or fourth-line biologic. Actual coverage and reimbursement decisions are made by individual payers following the receipt of claims. Coverage information is subject to change by the relevant payer.
†Limitations apply. Up to a $16,000 annual limit. Offer not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. Limitations may apply in MA and CA. For complete Terms & Conditions details, call 1-844-267-3689.
‡Certain payers have carve-outs that restrict utilization of manufacturer support programs.
≬Covered Until You're Covered Program: Eligible patients must have commercial insurance, a valid prescription for COSENTYX, and a denial of insurance coverage based on a prior authorization request. Program requires the submission of an appeal of the coverage denial within the first 90 days of enrollment in order to remain eligible. Program provides initial 5 weekly doses (if prescribed) and monthly doses for free to patients for up to two years or until they receive insurance coverage approval, whichever occurs earlier. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Patients may be asked to reverify insurance coverage status during the course of the program. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Limitations may apply. Enrolled patients awaiting coverage for COSENTYX after two years may be eligible for a limited Program extension. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice.
References: 1. Data on file. COSENTYX Access. Novartis Pharmaceuticals Corp; January 2022. 2. Data on file. COSENTYX PSS Co-pay Data. Novartis Pharmaceuticals Corp; August 2020.